NO20085308L - Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser - Google Patents
Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelserInfo
- Publication number
- NO20085308L NO20085308L NO20085308A NO20085308A NO20085308L NO 20085308 L NO20085308 L NO 20085308L NO 20085308 A NO20085308 A NO 20085308A NO 20085308 A NO20085308 A NO 20085308A NO 20085308 L NO20085308 L NO 20085308L
- Authority
- NO
- Norway
- Prior art keywords
- group
- cycloalkyl
- iia
- mixtures
- hydrogen atom
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000002978 peroxides Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- 230000000078 anti-malarial effect Effects 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- -1 cyclic peroxide Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000006168 tricyclic group Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det beskrives dualmolekyler med formel (I) der: A er en molekylær rest med antimalariaaktivitet, med formel (Ila) eller (Illa), eller en rest som letter biotilgjengelighet; B er en cykloalkylgruppe som eventuelt er substituert, eller B representerer en bi- eller tricyklisk gruppe som kan substitueres, eller B representerer 2 cykloalkylgrupper bundet sammen via enten en enkeltbinding eller en alkylenkjede; m og n uavhengig av hverandre er 0, 1 eller 2; R5 er et hydrogenatom, en alkyl-, cykloalkyl- eller C1-3-alkylen-cykloakylgruppe; Z1 og Z2 er en alkylrest, gruppen Z1 + Z2 + Ci + Cj representerer en mono- eller polycyklisk struktur, der en av Z1 eller Z2 er i stand til å representere en enkeltbinding; R1 og R2 er like eller forskjellige og er et hydrogenatom eller en funksjonell gruppe i stand til å øke vannoppløseligheten; Rx og Ry sammen danner et cyklisk peroksid med 4 til 8 bindinger og som inkluderer et eller to ytterligere oksygenatomer i den cykliske struktur, eventuelt substituert med en eller flere R3 grupper; som en base eller som et salt for addisjon til en syre, som et hydrat eller solvat, i racemisk form, samt isomerer og deres blandinger, i tillegg til deres diastereoisomerer og blandinger derav. Det beskrives videre fremstillingsmetoder og anvendelse som medikamenter med antimalariaaktivitet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605235A FR2902100A1 (fr) | 2006-06-13 | 2006-06-13 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
PCT/FR2007/000946 WO2007144487A2 (fr) | 2006-06-13 | 2007-06-08 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085308L true NO20085308L (no) | 2009-03-12 |
Family
ID=37719816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085308A NO20085308L (no) | 2006-06-13 | 2008-12-18 | Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser |
Country Status (24)
Country | Link |
---|---|
US (1) | US20120122923A1 (no) |
EP (1) | EP2032561A2 (no) |
JP (1) | JP2009539946A (no) |
KR (1) | KR20090029208A (no) |
CN (1) | CN101466706A (no) |
AP (1) | AP2008004711A0 (no) |
AR (1) | AR061347A1 (no) |
AU (1) | AU2007259116A1 (no) |
BR (1) | BRPI0713739A2 (no) |
CA (1) | CA2665940A1 (no) |
CR (1) | CR10469A (no) |
EA (1) | EA200970002A1 (no) |
EC (1) | ECSP088958A (no) |
FR (1) | FR2902100A1 (no) |
IL (1) | IL195394A0 (no) |
MA (1) | MA30577B1 (no) |
MX (1) | MX2008015980A (no) |
NO (1) | NO20085308L (no) |
PE (1) | PE20080335A1 (no) |
TN (1) | TNSN08462A1 (no) |
TW (1) | TW200817376A (no) |
UY (1) | UY30413A1 (no) |
WO (1) | WO2007144487A2 (no) |
ZA (1) | ZA200810012B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
ES2609578T3 (es) | 2011-03-04 | 2017-04-21 | Glaxosmithkline Intellectual Property Development Limited | Amino-quinolinas como inhibidores de quinasa |
TWI547494B (zh) | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
AR092530A1 (es) | 2012-09-13 | 2015-04-22 | Glaxosmithkline Llc | Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento |
TWI592417B (zh) | 2012-09-13 | 2017-07-21 | 葛蘭素史克智慧財產發展有限公司 | 胺基喹唑啉激酶抑制劑之前藥 |
TWI630203B (zh) | 2013-02-21 | 2018-07-21 | 葛蘭素史克智慧財產發展有限公司 | 做為激酶抑制劑的喹唑啉類 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
ES2162110T3 (es) * | 1995-11-16 | 2001-12-16 | Hoffmann La Roche | Derivados de la quinolina antimalaria. |
JP2002513005A (ja) * | 1998-04-29 | 2002-05-08 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Mrs阻害剤および殺菌剤用のキノロン類 |
FR2807433B1 (fr) * | 2000-04-06 | 2002-09-20 | Centre Nat Rech Scient | Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques |
US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
WO2003070244A1 (en) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagonist of melanin concentrating hormone and their uses |
SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
US20050256157A1 (en) * | 2002-08-23 | 2005-11-17 | Chiron Corporation | Combination therapy with CHK1 inhibitors |
KR20050037585A (ko) * | 2002-08-23 | 2005-04-22 | 카이론 코포레이션 | 벤지미다졸 퀴놀리논 및 그들의 사용 |
US20050197350A1 (en) * | 2003-03-31 | 2005-09-08 | Taisho Pharmaceutical Co., Ltd. | Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
HU227684B1 (en) * | 2003-08-29 | 2011-11-28 | Sanofi Aventis | Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors |
FR2862304A1 (fr) * | 2003-11-14 | 2005-05-20 | Centre Nat Rech Scient | Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
WO2005066132A1 (en) * | 2004-01-07 | 2005-07-21 | Astrazeneca Ab | Therapeutic agents i |
WO2006028545A2 (en) * | 2004-06-18 | 2006-03-16 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
FR2889525A1 (fr) * | 2005-08-04 | 2007-02-09 | Palumed Sa | Nouveaux derives de polyquinoleines et leur utilisation therapeutique. |
-
2006
- 2006-06-13 FR FR0605235A patent/FR2902100A1/fr not_active Withdrawn
-
2007
- 2007-06-08 MX MX2008015980A patent/MX2008015980A/es active IP Right Grant
- 2007-06-08 BR BRPI0713739-7A patent/BRPI0713739A2/pt not_active IP Right Cessation
- 2007-06-08 CN CNA2007800218550A patent/CN101466706A/zh active Pending
- 2007-06-08 EP EP07788851A patent/EP2032561A2/fr not_active Withdrawn
- 2007-06-08 AP AP2008004711A patent/AP2008004711A0/xx unknown
- 2007-06-08 JP JP2009514836A patent/JP2009539946A/ja not_active Withdrawn
- 2007-06-08 KR KR1020087030376A patent/KR20090029208A/ko not_active Application Discontinuation
- 2007-06-08 CA CA002665940A patent/CA2665940A1/fr not_active Abandoned
- 2007-06-08 ZA ZA200810012A patent/ZA200810012B/xx unknown
- 2007-06-08 WO PCT/FR2007/000946 patent/WO2007144487A2/fr active Application Filing
- 2007-06-08 AU AU2007259116A patent/AU2007259116A1/en not_active Abandoned
- 2007-06-08 EA EA200970002A patent/EA200970002A1/ru unknown
- 2007-06-12 AR ARP070102553A patent/AR061347A1/es not_active Application Discontinuation
- 2007-06-12 PE PE2007000739A patent/PE20080335A1/es not_active Application Discontinuation
- 2007-06-13 UY UY30413A patent/UY30413A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121347A patent/TW200817376A/zh unknown
-
2008
- 2008-11-17 TN TNP2008000462A patent/TNSN08462A1/en unknown
- 2008-11-19 IL IL195394A patent/IL195394A0/en unknown
- 2008-11-27 CR CR10469A patent/CR10469A/es not_active Application Discontinuation
- 2008-12-11 US US12/332,633 patent/US20120122923A1/en not_active Abandoned
- 2008-12-11 EC EC2008008958A patent/ECSP088958A/es unknown
- 2008-12-18 NO NO20085308A patent/NO20085308L/no not_active Application Discontinuation
-
2009
- 2009-01-06 MA MA31552A patent/MA30577B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007144487A2 (fr) | 2007-12-21 |
KR20090029208A (ko) | 2009-03-20 |
AU2007259116A1 (en) | 2007-12-21 |
AU2007259116A8 (en) | 2009-04-30 |
IL195394A0 (en) | 2009-08-03 |
TW200817376A (en) | 2008-04-16 |
WO2007144487A3 (fr) | 2008-02-07 |
CA2665940A1 (fr) | 2007-12-21 |
BRPI0713739A2 (pt) | 2013-06-18 |
MA30577B1 (fr) | 2009-07-01 |
MX2008015980A (es) | 2009-03-26 |
CN101466706A (zh) | 2009-06-24 |
TNSN08462A1 (en) | 2010-04-14 |
CR10469A (es) | 2009-02-26 |
EA200970002A1 (ru) | 2009-06-30 |
ZA200810012B (en) | 2010-05-26 |
PE20080335A1 (es) | 2008-05-22 |
ECSP088958A (es) | 2009-01-30 |
AR061347A1 (es) | 2008-08-20 |
FR2902100A1 (fr) | 2007-12-14 |
US20120122923A1 (en) | 2012-05-17 |
JP2009539946A (ja) | 2009-11-19 |
AP2008004711A0 (en) | 2008-12-31 |
UY30413A1 (es) | 2008-01-31 |
EP2032561A2 (fr) | 2009-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085308L (no) | Dualmolekyler inneholdende et peroksidderivat, deres syntese og deres terapautiske anvendelser | |
NO20076006L (no) | Acetylenderivater | |
CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
MX2010003445A (es) | Derivados de nicotinamida, su preparacion y su uso terapeutico. | |
ECSP088253A (es) | Derivados de azol y tiazol y sus usos | |
NO20083520L (no) | Tricykliske N-heteroaryl-karboksamidderivater inneholdende en benzimidazolenhet, fremgangsmate for fremstilling av samme og deres terapeutiske anvendelser | |
PE20080318A1 (es) | Derivados de diceto-piperazina y piperidina como agentes antivirales | |
CL2009000127A1 (es) | Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1. | |
WO2008115098A3 (fr) | 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation | |
PE20070491A1 (es) | Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina | |
AU2006325931A8 (en) | Amine compound and use thereof for medical purposes | |
WO2004089366A8 (en) | Bicyclic compounds as nr2b receptor antagonists | |
DK1730147T3 (da) | Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme | |
DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
WO2010089510A3 (fr) | Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique | |
TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
MX2010002662A (es) | Aminoquinolonas espirociclicas como inhibidores de gsk-3. | |
AR087302A1 (es) | Derivados aza heterociclicos sustituidos | |
NO20080871L (no) | N-(Heteroaryl)-1-heteroarylalkyl-1 H-indol-2-karboksamidderivater, fremstilling og terapeutisk anvendelse derav | |
TW200800962A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
HUP0400682A2 (hu) | 5-Hidroxitriptamin-6-ligandumként használható heterociklilalkilindol- és -azaindol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
TW200740795A (en) | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions | |
NO20054092L (no) | Nye tricykliske azepinforbindelser, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
AR071619A1 (es) | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen. | |
TW200738681A (en) | Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |